These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2827818)

  • 21. Familial male breast cancer. A case report and review of the literature.
    Hashishe MM; Kohail HM
    J Egypt Public Health Assoc; 1992; 67(5-6):639-53. PubMed ID: 1338210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S
    Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic types of breast cancer: their prognoses.
    Gallager HS
    Cancer; 1984 Feb; 53(3 Suppl):623-9. PubMed ID: 6318954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of breast carcinoma III: relationship of family history to tumor type.
    Rosen PP; Lesser ML; Senie RT; Kinne DW
    Cancer; 1982 Jul; 50(1):171-9. PubMed ID: 6282433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linell classification of breast cancer morphology compared to histologic grading, S-phase fraction and DNA-ploidy.
    Söderström J; Arnerlöv C; Emdin SO; Lundgren B; Roos G; Bjersing L; Norberg C; Angquist KA
    Pathol Res Pract; 1997; 193(7):485-90. PubMed ID: 9342754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bilateral breast carcinoma].
    Kasumi F
    Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):266-79. PubMed ID: 2984536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An expert system for histological typing and grading of invasive breast cancer. First set up.
    van Diest PJ; Belien JA; Baak JP
    Pathol Res Pract; 1992 Jun; 188(4-5):405-9. PubMed ID: 1329049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemically detected p53 and HER-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas.
    Auranen A; Grénman S; Kleml PJ
    Cancer; 1997 Jun; 79(11):2147-53. PubMed ID: 9179061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral familial breast cancer.
    Willis J; Shine M
    Ir Med J; 1986 Nov; 79(11):317-9. PubMed ID: 3026993
    [No Abstract]   [Full Text] [Related]  

  • 31. Case report: breast cancer in males--a genetic consideration.
    Stephens RL; Schimke RN
    Am J Med Sci; 1992 Aug; 304(2):91-2. PubMed ID: 1323932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Classification and prognosis of breast cancer. Histological studies of 854 breast tumors in 1963-1973].
    Herting W; Gresselmeyer G
    Fortschr Med; 1974 Dec; 92(34):1398-9. PubMed ID: 4376118
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial male breast carcinoma.
    Demeter JG; Waterman NG; Verdi GD
    Cancer; 1990 May; 65(10):2342-3. PubMed ID: 2161282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic typing in breast cancer. Further investigation of a necropsy series compared with recent surgical specimens.
    Maehle BO; Hartveit F
    J Clin Pathol; 1973 Oct; 26(10):784-91. PubMed ID: 4356265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
    Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
    Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between breast histopathology and family history of breast cancer.
    Claus EB; Risch N; Thompson WD; Carter D
    Cancer; 1993 Jan; 71(1):147-53. PubMed ID: 8380113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
    Xu J; Li F; Chang F
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    Kassardjian A; Shintaku PI; Moatamed NA
    PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.